Literature DB >> 21640807

Delivery devices for the administration of paediatric formulations: overview of current practice, challenges and recent developments.

Jennifer Walsh1, Deborah Bickmann, Joerg Breitkreutz, Maryvonne Chariot-Goulet.   

Abstract

The European Paediatric Formulation Initiative (EuPFI), a group consisting of paediatric formulation experts from industry, academia and clinical pharmacy was founded with the aim of raising awareness of paediatric formulation issues. It is imperative that paediatric medicines can be administered accurately to ensure the correct dose is provided and that the administration device is easy to use and acceptable from the patient's and carer's perspectives. This reflection paper provides an overview of currently available paediatric administration devices and highlights some of the challenges associated with, recommendations and recent developments in delivery devices for the oral, inhaled, parenteral, nasal and ocular administration of paediatric formulations, on behalf of the EuPFI.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21640807     DOI: 10.1016/j.ijpharm.2011.05.048

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  27 in total

Review 1.  Challenges Associated with Route of Administration in Neonatal Drug Delivery.

Authors:  Matthew W Linakis; Jessica K Roberts; Anita C Lala; Michael G Spigarelli; Natalie J Medlicott; David M Reith; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2016-02       Impact factor: 6.447

Review 2.  Educational paper: formulation-related issues in pediatric clinical pharmacology.

Authors:  Catherine Tuleu; Joerg Breitkreutz
Journal:  Eur J Pediatr       Date:  2012-10-31       Impact factor: 3.183

Review 3.  Moving toward a paradigm shift in the regulatory requirements for pediatric medicines.

Authors:  William Wei Lim Chin; Angelika Joos
Journal:  Eur J Pediatr       Date:  2016-09-19       Impact factor: 3.183

Review 4.  The bad taste of medicines: overview of basic research on bitter taste.

Authors:  Julie A Mennella; Alan C Spector; Danielle R Reed; Susan E Coldwell
Journal:  Clin Ther       Date:  2013-07-22       Impact factor: 3.393

Review 5.  A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms.

Authors:  Anne Zajicek; Michael J Fossler; Jeffrey S Barrett; Jeffrey H Worthington; Robert Ternik; Georgia Charkoftaki; Susan Lum; Jörg Breitkreutz; Mike Baltezor; Panos Macheras; Mansoor Khan; Shreeram Agharkar; David Douglas MacLaren
Journal:  AAPS J       Date:  2013-08-02       Impact factor: 4.009

Review 6.  A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research.

Authors:  Marilena M DeMayo; Yun Ju C Song; Ian B Hickie; Adam J Guastella
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

Review 7.  Pharmacokinetics of nanotechnology-based formulations in pediatric populations.

Authors:  Venkata K Yellepeddi; Andrea Joseph; Elizabeth Nance
Journal:  Adv Drug Deliv Rev       Date:  2019-09-05       Impact factor: 15.470

8.  Use of a disposable valved-holding chamber (spacer) in a school-based asthma trial.

Authors:  James L Goodwin; Lynn B Gerald; Jennifer L H Johnson; Joe K Gerald
Journal:  J Allergy Clin Immunol Pract       Date:  2017-09-29

9.  Acceptability of different oral formulations in infants and preschool children.

Authors:  Diana A van Riet-Nales; Barbara J de Neef; Alfred F A M Schobben; José A Ferreira; Toine C G Egberts; Catharine M A Rademaker
Journal:  Arch Dis Child       Date:  2013-07-13       Impact factor: 3.791

10.  Performance of dry powder inhalers with single dosed capsules in preschool children and adults using improved upper airway models.

Authors:  Sandra Lindert; Antje Below; Joerg Breitkreutz
Journal:  Pharmaceutics       Date:  2014-02-06       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.